A carregar...
A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular Edema
OBJECTIVE: To investigate the comparative efficacy of bevacizumab (Avastin(®)) and ranibizumab (Lucentis(®)) for diabetic macular edema (DME) using a crossover study design. DESIGN: Randomized, double-masked, 36-week, three-period crossover clinical trial. PARTICIPANTS: 56 subjects with DME involvin...
Na minha lista:
| Publicado no: | Ophthalmology |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4988394/ https://ncbi.nlm.nih.gov/pubmed/26875003 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2015.11.021 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|